K-numberK250443
Device nameMAGNETOM Avanto Fit; MAGNETOM Skyra Fit; MAGNETOM Sola Fit; MAGNETOM Viato.Mobile
ApplicantSiemens Healthcare GmbH
Product codeLNH
Device classClass II
Decision dateJun 16, 2025
DecisionSubstantially Equivalent
Regulation892.1000
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The MAGNETOM Avanto Fit, Skyra Fit, Sola Fit, and Viato.Mobile are magnetic resonance diagnostic devices that produce cross-sectional images and spectroscopic data of the head, body, or extremities to assist in clinical diagnosis. They can be used for standard MRI imaging and interventional procedures with MR-compatible accessories.

Technological characteristics

The subject devices incorporate new and modified software (syngo MR XA70A) and hardware compared to predicates. New hardware includes the myExam 3D Camera and BM Head/Neck 20 coil. New software features include myExam Autopilot Brain/Knee, 3D Whole Heart, Deep Resolve Gain/Sharp/Boost algorithms, Ghost Reduction, BLADE diffusion, and AutoMate Cardiac. Modified features include SPACE improvements, Brain Assist, and Eco power mode. The fundamental magnet, RF, gradient, and patient table systems remain essentially unchanged.

Test standards cited

Devices conform to IEC 62304 (medical device software lifecycle), IEC 60601-1-2 (electromagnetic safety), IEC 60601-2-33 (MR equipment safety), ISO 14971 (risk management), ISO 62366-1 (usability), NEMA MS 6-2008 (SNR/uniformity for coils), and NEMA DICOM PS 3.1-3.20 (digital imaging standards).

Substantial equivalence argument

The subject devices share identical intended use and basic technological architecture with their predicates across all four models. Although new AI-based features (Deep Resolve algorithms, AutoMate Cardiac), pulse sequences (BLADE diffusion, GRE_PC), and hardware (3D camera, new coil) are present, comprehensive nonclinical testing—including software verification/validation, sample clinical image assessment, coil performance benchmarking, and AI training/validation on large datasets—demonstrated that these features achieve equivalent safety and performance profiles to the predicate devices. The differences represent incremental enhancements within the same fundamental MR imaging platform, not fundamental design changes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →